These substances were identified for action under the third phase of Chemicals Management Plan (CMP).
|Substance group||CAS RN||Common name||DSL name||Public comment on the draft screening assessment||Final screening assessment||Proposed risk management approach||Conclusion on section 64 criteria||Follow-up activities|
|Thiocarbamates Group||137-26-8||TMTD, Thiram||Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), tetramethyl-||HTML||HTML||HTML||Meets one or more of the criteria||Refer to proposed risk management approach|
|120-54-7||DPTT||Piperidine, 1,1'-(tetrathiodicarbonothioyl)bis-||None||Does not meet||None planned at this time|
|January 9, 2021||Publication of the Final Screening Assessment for the Thiocarbamates Group. The Proposed Risk Management Approach for TMTD was also published for a 60-day public comment period. The related notice was published in the Canada Gazette, Part I, Vol. 155, No. 2.|
|February 3, 2018||Publication and start of 60-day public comment period on the Draft Screening Assessment for the Thiocarbamates Group (including follow-up activities for TMTD) and the Risk Management Scope for TMTD. The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 5.|
Report a problem or mistake on this page
- Date modified: